Amitriptyline as a First‑Generation Tricyclic Antidepressant

Classification and Historical Context

• Amitriptyline is classified as a first‑generation antidepressant and specifically as a tricyclic antidepressant (TCA). 1
• First‑generation antidepressants comprise TCAs and monoamine oxidase inhibitors (MAOIs). Amitriptyline belongs to this class. 2

Comparative Efficacy and Safety

• First‑generation agents such as amitriptyline are rarely used as first‑line therapy because second‑generation antidepressants demonstrate comparable efficacy with lower toxicity in overdose situations. 3
• In severely depressed hospitalized patients, amitriptyline may provide superior efficacy compared with selective serotonin reuptake inhibitors (SSRIs); this advantage is not observed in outpatient settings. 4

Guideline Recommendations

• The American College of Physicians recommends second‑generation antidepressants as the first‑line pharmacologic treatment for acute major depressive disorder, citing their more favorable adverse‑effect profile relative to first‑generation agents like amitriptyline. 5

Pharmacologic Characteristics

• Amitriptyline is a tertiary‑amine TCA (along with clomipramine and imipramine) that inhibits the reuptake of both norepinephrine and serotonin, providing dual neurotransmitter activity. 6

Safety Considerations in Older Adults

• According to the American Geriatric Society’s Beers Criteria, tertiary‑amine TCAs such as amitriptyline are considered potentially inappropriate medications for older adults because of significant anticholinergic adverse effects. 7